COMPREHENSIVE MANAGEMENT OF PARKINSONIAN PATIENTS WITH BOTULINUM TOXIN MAJA TROŠT DEPARTMENT FOR NEUROLOGY.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

What is Cerebral Palsy. Cerebral – Brain Palsy – weakness, paralysis or lack of muscle control. Cerebral Palsy (CP) is a permanent physical condition.
Surgical management: DBS and effects on gait, posture and falls overview Miguel Coelho, MD Neurology Department, Hospital Santa Maria Clinical Pharmacology.
Leslie Cloud, MD Department of Neurology Division of Movement Disorders Emory University School of Medicine.
Cervical Dystonia. Originally known as spasmodic torticollis and first described by Foltz in 1959, is a neurological syndrome characterized by abnormal.
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
Therapeutic Uses of Botulinum Toxin in Neuro-ophthalmology Janette I. Lindley, MD FRCSC St. Paul’s Hospital University of British Columbia.
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Objectives Define urinary incontinence
MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.
OnabotulinumtoxinA for Urinary Incontinence from Neurogenic Detrusor Overactivity.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
Dr. Kleyn Department of Geriatric Medicine SVCMC
kyphosis lordosis and scoliosis
Movement Disorders General Overview. BASAL GANGLIA CIRCUITRY.
הפרעות תנועה והטיפול בבוטולינום טוקסין ד" ר מריאטה אנקה הרשקוביץ מנהלת מרפאה להפרעות תנועה מרפאה נוירולוגית בית חולים ע"ש אדית וולפסון.
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Continence in the very aged Mark Weatherall University of Otago, Wellington.
Weight Loss and Wheezing. A 78-year-old woman presented because of daily episodes of shortness of breath.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Ultrasound Guided Botulinum Toxin Injection for Sialorrhoea in Parkinson’s Disease; Evidence, Technique and Outcomes Background Sialorrhoea: inability.
GERIATRICS : UI Dr. Meg-angela Christi Amores. URINARY INCONTINENCE  major problem for older adults, afflicting up to 30% of community-dwelling elders.
Parkinson’s Disease superKAT :).
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Parkinson’s disease – diagnosis in the bowel? David Hilton Department of Cellular and Anatomical Pathology, Derriford Hospital, Plymouth.
10 Second Case Studies Round 2: Degenerative Neurological Conditions.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Clinical Approach to Neurologic Disorders Anatomic Pathophysiologic Phenomenologic Symptomatic Protective Curative Surgical.
Medication Induced Movement Disorders Jacob Alexander July 2012 Rural & Remote Mental Health Service.
Sharon English Urologist Christchurch
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Teaching NeuroImages Neurology Resident and Fellow Section A 77 year-old woman with Parkinson’s disease exhibits re- emergent jaw tremor. © 2015 American.
 Strength decline  Longer delays of reactions  Impaired control of posture/gait  Impaired accurate control of force/movement  Unintended force production.
Controlling Urine Leakage What You Need To Know David Spellberg MD,FACS Controlling Urine Leakage What You Need To Know David Spellberg MD,FACS.
Botox Injections. MetroMD Institute of Regenerative Medicine Botox Injections What is botox? How does botox work? Botox is a drug made from a neurotoxin.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
Acetyl Hexapeptide-8 for Treatment of Blepharospasm Codrin Lungu, MD Medical Neurology, NINDS, NIH.
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
CLINICAL SIGNIFICANCE
Understanding Parkinsons Disease
Parkinson’s Disease Jose S. Santiago M.D..
Involuntary movements in Parkinson’s disease: not always what it seems
WORLD FEDERATION OF NEUROSCIENCE NURSES
METHODS AND MATERIALS: SCIENTIFIC/CLINICAL SIGNIFICANCE:
Botox and Its Role in Parkinson’s Disease
Causes | Symptoms | Treatments
BOTOX – By Dutchess Neurology
Teaching Video NeuroImages Neurology Resident and Fellow Section
Parkinson's disease KRZYSZTOF NICPOŃ.
Neurological History and Exam
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
A 58-year-old man with progressive stiffness
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Motor Fluctuations in Parkinson Disease: Options and Strategies
Atypical Parkinsonian Syndromes
Bladder Dysfunction Associated With Parkinson’s Disease
Portable Biofeedback for Bladder Control
Advanced Parkinson Disease: Are We Breaking New Ground?
Parkinson’s Disease Definitions Disease features Pathology
(A) Frontalis test: unilateral injection of the frontalis muscle with botulinum toxin (BoNT). (A) Frontalis test: unilateral injection of the frontalis.
Motor Fluctuations in PD
Presentation transcript:

COMPREHENSIVE MANAGEMENT OF PARKINSONIAN PATIENTS WITH BOTULINUM TOXIN MAJA TROŠT DEPARTMENT FOR NEUROLOGY

PARKINSON’S DISEASE Motor & non motor symptoms impair QoL Many are resistant to conventional treatment

Indications for BoNT treatment in PD Limb dystonia Blepharospasm & apraxia of eyelid opening Bruxism Antecollis Camptocormia Tremor (hand and jaw) Painful shoulder (due to rigidity) Freezing of gait Sialorrhea Dysphagia Seborrhea Hyperhidrosis Overactive bladder Constipation

DYSTONIA IN PD Affects 60% of patients Risk factors for dystonia in PD: young age, female gender, long disease duration Side effect of levodopa treatment Mechanism? Jankovic and Stacy 2007, Jankovic and Tintner 2001

Blepharospasm & lid apraxia More common in PSP Mechanism? Hallett et al 2008, Elston 1992, Krack and Marion 1994

BoNT treatment Time form injection to improvement: 3-5 days Duration of benefit: 3-4 months Frowning pre and after BoNT Hirota et al 2008

Therapeutics and Technology Assessment Subcommittee of the AAN: level B (probably effective) evidence for its efficacy, and recommended that ‘‘BoNT injection should be considered as a treatment option for blepharospasm’’ Simpson et al 2008

Bruxism Focal oromandibular dystonia Study: 18 pts with severe bruxism m. masseter BoNT injection 1 transient dysphagia 3.4 ± 0.9 improvement (0-4) Tan and Jankovic, 2000

Limb dystonia Foot dystonia – striatal foot Striatal hand Jankovic 2005

Dystonic clenched fist Levodopa related dyskinesia (painful off stage dystonia) Jankovic and Stacy 2007, Pacchetti et al 1995

Neck dystonia Antecollis is most common in PD & MSA

Axial dystonia & camptocormia Cervical dystonia Abnormal trunk posture (scoliosis, kyphosis, camptocormia, pisa syndrome)

Camptocormia BoNT in rectus abdominis: 9/11 pts improved No effect of BoNT of the iliopsoas muscles Azher, Jankovic 2005; von Coelln et al., 2008, Mahjneh e tal. 2009, Colosimo, Salvatori 2009

Tremor Re-emergent tremor interferes more with QoL then rest tremor Th: BoNT, DBS

Tremor Two double blind, placebo controlled studies with BoNT for essential tremor: safe and effective in reducing of tremor amplitude, but weakness of finger extensors appeared No significant effect in PD tremor Jaw tremor (BoNT in masseter muscles) Jankovic et al 1996, Brin et al 2001, Schneider et al 2006

Freezing of gait Mechanism? Dystonic, disinhibited foot grasp (Brown, 1958) BoNT in distal leg muscles was not effective

Sialorrhea Affects 75% of PD pts Causes social handicap, skin irritation, infection BoNT in submandibular and parotid glands All types of BoNT are useful Side effects: dysphagia, xerostomia Myobloc side effect: dry mouth… Jankovic, 2008, 2009, Gomez-Caravaca et al. 2014

 Egevad et al. 2014

Dysphagia/achalasia Mechanism: degeneration of motor nucleus of n. X, Lewy bodies in myenteric plexus of the esophagus, flexed neck, achalasia Th: BoNT in lower esophageal sphincter

Overactive bladder Therapeutics and Technology Assessment Subcommittee of the AAN concluded that there is level A evidence for the recommendation that BoNT should be offered as a treatment option for neurogenic detrusor overactivity BoNT into bladder wall to increase bladder capacity and to improve urge and incontinence Patel 2006, Naumann et al 2008, Giannantoni et al 2009, Kulaksizoglu, Parman 2010

Constipation Anismus: focal dystonia of striated sphincter muscles at the pelvic outlet Several open-label studies demonstrated the benefic Mathers et al 1988, Albanese et al 2003, Cadeddu et al 2005

Thank you!